Industry Experts

Vickie Tsui has >25 years of industry experience and is currently Executive Director at Gilead Sciences in the Structural Biology and Chemistry department. She leads the Computational Modeling group, which uses AI/ML as well as more traditional methods for Small Molecule Drug Discovery. Prior to Gilead, Vickie worked at Genentech’s Computer-Aided Drug Discovery group and at SGX. Vickie obtained her Ph.D. from the Scripps Research Institute in Professor David Case’s lab.